Loading…
SeaStar Medical Holding Corporation is projected to rise to $7.83 by 2027, a +58% move from its current price of $4.95. ICU is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $4.65 | $4.95 | $5.27 | +0.03% |
| Jul 15 | $4.53 | $4.95 | $5.41 | +0.07% |
| Jul 16 | $4.44 | $4.96 | $5.52 | +0.10% |
| Jul 17 | $4.37 | $4.96 | $5.62 | +0.14% |
| Jul 18 | $4.31 | $4.96 | $5.71 | +0.17% |
| Jul 19 | $4.25 | $4.96 | $5.79 | +0.21% |
| Jul 20 | $4.20 | $4.96 | $5.86 | +0.24% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.20 | $4.96 | $5.86 | +0.24% |
| Week 2 | $3.93 | $4.97 | $6.29 | +0.48% |
| Week 3 | $3.74 | $4.99 | $6.65 | +0.72% |
| Week 4 | $3.58 | $5.00 | $6.97 | +0.96% |
| Week 5 | $3.45 | $5.01 | $7.27 | +1.21% |
| Week 6 | $3.34 | $5.02 | $7.55 | +1.45% |
| Week 7 | $3.24 | $5.03 | $7.81 | +1.69% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
SeaStar Medical Holding Corporation is a commercial-stage healthcare company that develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease.
SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.
SeaStar Medical Holding Corporation (ICU) trades at $4.92 per share and has a market cap of $19.67M. The company ranks 4,776 by market cap.
The current technical backdrop is bullish, with RSI14 at 70. SMA50 is $3.76 and SMA200 is $3.88. The stock shows support at $2.63 and resistance at $4.92, framing a near-term channel that aligns with the latest price action.
A major floor 64.2% below — a decisive break under it would weaken the trend.
The nearest floor, 46.9% below — buyers have tended to step in here.
Price is pressing into resistance (2.6% away) — a breakout level to watch.
A major ceiling 34.7% above — clearing it would confirm fresh momentum.
Key ICU support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ICU market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.95 | Sell | $4.86 | Buy |
| MA 10 | $4.49 | Buy | $4.54 | Buy |
| MA 20 | $3.79 | Buy | $4.12 | Buy |
| MA 50 | $3.84 | Buy | $3.81 | Buy |
| MA 100 | $3.50 | Buy | $3.77 | Buy |
| MA 200 | $3.78 | Buy | $6.20 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 68.45 | Neutral |
| Stoch RSI (14) | 85.75 | Sell |
| CCI (20) | 96.54 | Neutral |
| Williams %R (14) | -6.19 | Info |
| MACD (12,26,9) | 0.19 | Buy |
| ROC (12) | 42.65 | Buy |
| Bollinger %B (20,2) | 0.84 | Neutral |
| Stochastic %K (14) | 93.81 | Sell |
| TRIX (15) | 0.81 | Buy |
| Awesome (5,34) | 1.34 | Buy |
| Ultimate (7,14,28) | 77.84 | Sell |
| Momentum (10) | 1.97 | Buy |
| Aroon Osc (25) | 72.00 | Buy |
| Hull MA (9) | 5.17 | Sell |
| ADX (14) | 27.73 | Buy |
| ATR (14) | 0.20 | Info |
The 30-day technical picture is bullish, supported by a strong RSI reading of 70. The stock is trading above both the SMA50 of $3.76 and the SMA200 of $3.88, suggesting some upside momentum.
Key near-term levels include support at $2.63 and resistance at $4.92. The 30-day range extends from $3.07 up to $7.88, highlighting a broad trading window that could influence near-term moves.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.21 | $4.95 | $7.02 | 0% | Neutral | |
| $5.68 | $7.83 | $11.67 | +58% | Bullish | |
| $5.83 | $8.54 | $13.57 | +73% | Bullish | |
| $5.57 | $8.59 | $14.32 | +74% | Bullish | |
| $5.55 | $8.98 | $15.59 | +82% | Bullish | |
| $4.74 | $8.01 | $14.39 | +62% | Bullish | |
| $5.88 | $10.37 | $19.22 | +110% | Bullish | |
| $8.21 | $15.08 | $28.71 | +205% | Bullish | |
| $8.46 | $16.16 | $31.54 | +226% | Bullish | |
| $8.07 | $16.01 | $31.99 | +224% | Bullish | |
| $12.76 | $28.37 | $62.27 | +473% | Bullish | |
| $15.03 | $33.41 | $76.84 | +575% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $2.21 | $4.95 | $6.33 | +0.00% |
| August 2026 | $4.19 | $5.08 | $6.41 | +2.64% |
| September 2026 | $4.16 | $5.11 | $6.58 | +0.52% |
| October 2026 | $4.45 | $5.54 | $7.26 | +8.45% |
| November 2026 | $4.44 | $5.57 | $7.41 | +0.63% |
| December 2026 | $4.11 | $5.21 | $7.02 | -6.51% |
Click any year to see its month-by-month ICU forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, ICU could reach as high as $7.02, with a base case around $4.95 and support toward $2.21 — roughly 0% from $4.95. Price action looks broadly range-bound.
Expect ICU to range from $5.68 to $11.67 through 2027. The $7.83 average target implies a +58% move from current prices. That is up +58% on the projected 2026 average. Buyers look set to stay in control over this stretch.
The ICU price prediction for 2028 points to an average of $8.54 (low $5.83, high $13.57) — a potential gain of +73% on today's $4.95. Momentum favours further upside here.
In 2029, ICU is projected to trade between $5.57 and $14.32, averaging $8.59 — a potential gain of +74% from today's $4.95. That is up +1% on the projected 2028 average. Buyers look set to stay in control over this stretch.
SeaStar Medical Holding Corporation's 2030 outlook centres on $8.98, within a $5.55 to $15.59 range. That is up +5% on the projected 2029 average. That marks a +82% change versus current levels. Momentum favours further upside here.
By 2031, ICU could reach as high as $14.39, with a base case around $8.01 and support toward $4.74 — roughly +62% from $4.95. Buyers look set to stay in control over this stretch.
Expect ICU to range from $5.88 to $19.22 through 2032. The $10.37 average target implies a +110% move from current prices. That is up +30% on the projected 2031 average. Momentum favours further upside here.
The ICU price prediction for 2033 points to an average of $15.08 (low $8.21, high $28.71) — a potential gain of +205% on today's $4.95. Buyers look set to stay in control over this stretch.
In 2034, ICU is projected to trade between $8.46 and $31.54, averaging $16.16 — a potential gain of +226% from today's $4.95. That is up +7% on the projected 2033 average. Momentum favours further upside here.
SeaStar Medical Holding Corporation's 2035 outlook centres on $16.01, within a $8.07 to $31.99 range. That is -1% versus the projected 2034 average. That marks a +224% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, ICU could reach as high as $62.27, with a base case around $28.37 and support toward $12.76 — roughly +473% from $4.95. Momentum favours further upside here.
Expect ICU to range from $15.03 to $76.84 through 2050. The $33.41 average target implies a +575% move from current prices. That is up +18% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in ICU today (≈ 202.020202 ICU) could be worth
$6,748.9
+$5,748.9 (+575%) by 2050 · US Dollar
Based on the average projected ICU price of $33.41 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ICUwould be worth at today's price.
$1,000 invested in ICU on Jul 10, 2025 (≈ 162.866453 ICU) would be worth
$806.19
-$193.81 (-19.4%) today · 0.81× · US Dollar
Based on a ICU entry price of $6.14 vs. today's $4.95.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.92 | $1,006.1 | +0.6% |
| 1 month ago | $2.63 | $1,882.13 | +88.2% |
| 3 months ago | $3.71 | $1,334.23 | +33.4% |
| 6 months ago | $2.3 | $2,152.17 | +115.2% |
| 1 year ago | $6.14 | $806.19 | -19.4% |
| All time (5.0y) ago | $2,470 | $2 | -99.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ICU forecast.
Our base-case forecast reaches $9.90 around 2032.
Implied market cap at $9.90: $39.57M
The multi-year forecast outlines a rising price path with distinct milestones. In 2026, the avg price is $4.92 with a min of $2.21 and a max of $7.21, and ROI 0; sentiment is NEUTRAL. In 2027 the avg rises to $8.26 (min $5.98, max $12.33; ROI 67.9; sentiment BULLISH).
2028 shows an avg of $8.98 (min $6.12, max $14.27; ROI 82.5; sentiment BULLISH), and 2029 expects an avg of $9.23 (min $5.97, max $15.40; ROI 87.5; sentiment BULLISH). By 2030 the avg reaches $10.23 (min $6.32, max $17.77; ROI 107.9; sentiment BULLISH) and 2031 projects $9.23 (min $5.46, max $16.60; ROI 87.7; sentiment BULLISH). The trajectory continues with 2032 at $13.14 avg and 2033 at $19.43 avg (ROI 167.2 and 295 respectively), 2034 at $19.73 avg (ROI 301), and 2035 at $20.10 avg (ROI 308.5) — all listed as BULLISH.
The forecast accelerates considerably in 2040 to an avg of $38.50 (min $17.32, max $84.54; ROI 682.4; sentiment BULLISH) and culminates in 2050 with an avg of $48.66 (min $21.90, max $111.92; ROI 889; sentiment BULLISH). These figures imply a longer-run bullish trajectory, albeit with inherent uncertainty and the estimates nature of the data.
Tap a question to reveal the answer.
The 2030 forecast shows an avg price of $10.23 with a min of $6.32 and a max of $17.77, and a forecast ROI of 107.9 with bullish sentiment.
The forecast shows a progression to bullish sentiment from 2027 onward, with higher average prices in subsequent years (e.g., $8.26 in 2027, $10.23 in 2030, $38.50 in 2040, $48.66 in 2050) and rising ROIs (up to 889 in 2050). The 2026 figure is neutral and the current price is $4.92 with a market cap of $19.67M, adding context but not guaranteeing future results.
According to the forecast, the 2029 max is $15.40, suggesting a potential to reach around $15 in that year based on the modeled path.
The 2040 forecast shows an avg price of $38.50 with a min of $17.32 and a max of $84.54, and a forecast ROI of 682.4 with bullish sentiment.
Current price is $4.92 and market cap is $19.67M.
SeaStar Medical Holding Corporation Community Discussion
0Share your SeaStar Medical Holding Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.